EGMSILVAPHL

SILVAPHL Corporate Disclosure — 16 November 2025

Published
Last verified by BullBD

Announcement summary

What happened
SILVAPHL published a corporate disclosure on 16 November 2025. Read the full announcement for details.
Company
Silva Pharmaceuticals Limited
Announcement published

Original announcement

The Board of Directors of the company has taken the following decisions, which are subject to the approval by the Shareholders at the upcoming EGM and BSEC. 1) Change of Company name and Amend the AoA; 2) Post-Facto Approval of Project Revisions; and 3) Revised Proposal for utilization of IPO Proceeds. (cont.)

বাংলা অনুবাদ — BullBD

This is a BullBD translation of the published corporate disclosure.

কোম্পানির পরিচালনা পর্ষদ নিম্নলিখিত সিদ্ধান্তগুলি নিয়েছে, যা আসন্ন EGM এবং BSEC-তে শেয়ারহোল্ডারদের অনুমোদন সাপেক্ষে। ১) কোম্পানির নাম পরিবর্তন এবং AoA সংশোধন; ২) প্রকল্প সংশোধনের কার্যকর-পরবর্তী অনুমোদন; এবং ৩) IPO অর্থ ব্যবহারের জন্য সংশোধিত প্রস্তাব। (চলবে)

Source & verification

Source
Published company disclosure
Published through
Dhaka Stock Exchange
Announcement ID
69194a9cd64a2828d8c26a89
Original publication
Last verified by BullBD
Translation
BullBD
Report incorrect information

Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.